Updated Jan 22, 2021 | 12:00 IST
Shares of Biocon saw a steep fall after the drugmaker s results missed analyst estimates in the quarter ended December. Net profit declined 19% year-on-year as expenses rose significantly. Biocon earnings | Photo Credit: BCCL
Key Highlights
Biocon says it continues to face headwinds across operational, regulatory and commercial function Dr. Christiane Hamacher steps down as the Managing Director of Biocon Biologics Limited due to professional differences with the Chairperson on strategic priorities and vision for the company
Mumbai: Biocon was one of the top laggards on Dalal Street today as the company declared it’s earnings, however, the earnings were a miss compared to the consensus street estimates that were pencilled in. Below are the key highlights of the earnings report by Biocon.